HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

preladenant

structure in first source
Also Known As:
SCH 420814; SCH-420814; SCH420814
Networked: 12 relevant articles (2 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hauser, Robert A: 3 articles (12/2015 - 03/2011)
2. Stamford, Andrew W: 3 articles (10/2010 - 02/2009)
3. Tendolkar, A: 2 articles (10/2013 - 10/2012)
4. Cutler, D L: 2 articles (10/2013 - 10/2012)
5. Wolski, Kenneth: 2 articles (06/2013 - 03/2011)
6. Huyck, Susan: 2 articles (06/2013 - 03/2011)
7. Pourcher, Emmanuelle: 2 articles (06/2013 - 03/2011)
8. Cantillon, Marc: 2 articles (06/2013 - 03/2011)
9. Hunter, John C: 2 articles (10/2010 - 07/2009)
10. Neustadt, Bernard R: 2 articles (10/2010 - 02/2009)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Catalepsy
3. Dyskinesias (Dyskinesia)
4. Constipation
5. Parkinsonian Disorders (Parkinsonism)

Related Drugs and Biologics

1. Haloperidol (Haldol)
2. Levodopa (L Dopa)
3. Adenosine
4. Dopamine (Intropin)
5. (7- (2- (4- difluorophenyl)- 1- piperazinyl)ethyl)- 2- (2- furanyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidin- 5- amine
6. CF101
7. N-(3-tetrahydrofuranyl)-6-aminopurine riboside
8. 2- (cyclohexylmethylidenehydrazino)adenosine
9. Adenosine A2A Receptor (Adenosine A2A Receptors)
10. Dopamine D2 Receptors (Dopamine D2 Receptor)

Related Therapies and Procedures

1. Laser Therapy (Surgery, Laser)